Minor Narcotics Amendment (642)

An amendment to the Controlled Substances Act (Inter) to categorize certain drugs into a separate class.

''Passed in the General Assembly, June 27th, 2022. 11 Aye, 4 Nay, 3 Abstain.''

Amendment of Controlled Substances Act (Inter)
The Controlled Substances Act (Inter); This resolution aims to amend the Controlled Substances Act by adding an additional articles under the Act, which will define and include Minor Drugs (Schedule D & E).

Article 1 - Schedule E Drug

 * 1.1 - Schedule E is defined as drugs or substances that can act as either a stimulant or depressant.
 * 1.2 - Legalization of the sale, manufacture, and consumption of Schedule E drugs to people 18 and above.
 * 1.3 - The following will be labeled as Schedule E Drugs.
 * 1.3.1 - Nicotine
 * 1.3.1.1 - Defined as the chemical substance named 3-(1-Methyl-2-pyrrolidynyl) pyridine or C[10]H[14]N[2], including any salt or complex of nicotine.
 * 1.3.1.2 Levels of nicotine per tobacco product to be constrained to:
 * 1.3.1.2.1 - Cigarettes, to not exceed 1.8 milligrams (mg) per cigarette.
 * 1.3.1.2.2 - Cigars, to not exceed 15mg per cigar.
 * 1.3.1.2.3 - Mini-cigars, to not exceed 3.8mg per mini-cigar.
 * 1.3.1.2.4 - Chewing/Dipping can, to not exceed 88mg per can of chew/dip.
 * 1.3.1.2.5 - Loose leaf pouch, to not exceed 144mg per pouch.
 * 1.3.1.2.6 - E-liquid, to not exceed 18mg per 1 milliliter of e-liquid.
 * 1.3.2 - Cannabidiol (CBD)
 * 1.3.2.1 - Defined as the chemical substance named C[21]H[30]O[2].

Article 2 - Schedule D Drugs

 * 2.1 - Schedule D is defined as drugs or substances that can act as a stimulant, depressant, or sedative.
 * 2.2 - Schedule D Drugs must be prescribed by a licensed medical professional to be legally sold to the individual.
 * 2.3 - Legalization of the manufacturing and sale of Schedule D drugs to be limited to licensed facilities within the region.
 * 2.4 - The following to be labeled as Schedule D Drugs:
 * 2.4.1 - Tetrahydrocannabinol (THC)
 * 2.4.1.1 - Defined as the chemical substance named Delta-9-tetrahydrocannabinol or C[21]H[30]O[2].

Written and created by Yungly Shaon, MGA, CACSPO

Contributors: Tobias Virsturm, PGA, PPK